Patent details

EP2018160 Title: MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

Basic Information

Publication number:
EP2018160
PCT Application Number:
PCT/US/2007/006572
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP077532174
PCT Publication Number:
WO/2007/109104
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
French Title of Invention:
FORMULATIONS A LIBERATION MODIFIEE CONTENANT DES COMPLEXES MEDICAMENT - RESINE ECHANGEUSE D'IONS
German Title of Invention:
MODIFIZIERTE FREISETZUNGSFORMULIERUNGEN MIT ARZNEI-ION-AUSTAUSCH-HARZKOMPLEXEN
SPC Number:

Dates

Filing date:
15/03/2007
Grant date:
14/12/2011
EP Publication Date:
14/12/2011
PCT Publication Date:
27/09/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/01/2009
EP B1 Publication Date:
14/12/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/03/2012
Expiration date:
15/03/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/03/2007
 
 

Name:
Tris Pharma Inc.
Address:
2033 Route 130, Suite D., Monmouth Junction, NJ 08852, United States (US)

Inventor

1

Name:
TU Yu-hsing
Address:
United States (US)

2

Name:
MEHTA Ketan
Address:
United States (US)

Priority

Priority Number:
783181 P
Priority Date:
16/03/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/58;
Filing date Document type Number of pages